Paper Details

  1. Home
  2. Paper Details

Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia: An Overview of Systematic Reviews.

Author: HePeijie, JiConghua, LiQiushuang, LiangJuan, LinShengyun, WuHanting, XuXiujuan, ZhangWanjun

Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Hematopoietic stem cell transplantation (HSCT) is the main treatment for acute myeloid leukemia (AML), with allo-SCT showing better OS, RFS, and DFS than auto-SCT. While auto-SCT is associated with lower TRM, it generally has higher relapse rates. Further research is needed to fully explore the efficacy of different HSCT interventions in AML.
Paper Details　
Original Abstract of the Article :
BACKGROUND: Hematopoietic stem cell transplantation (HSCT) has become the main treatment for acute myeloid leukemia (AML) and has been studied in many systematic reviews (SRs), but strong conclusions have not been drawn yet. OBJECTIVE: This study aimed to summarize and critically evaluate the metho...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568333/

データ提供：米国国立医学図書館（NLM）

Hematopoietic Stem Cell Transplantation: A Vital Tool in the Fight Against Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a serious form of cancer affecting the blood and bone marrow. Hematopoietic stem cell transplantation (HSCT) is a complex and life-saving treatment for AML. This review article, published in [Journal Name], summarizes and evaluates systematic reviews on the use of HSCT for AML. It's like mapping out the various pathways through the desert of AML treatment, seeking the most effective and sustainable route to recovery.

Navigating the Landscape of HSCT for AML

The review highlights the benefits and risks of both autologous and allogeneic HSCT in the treatment of AML. It underscores the potential of HSCT to improve overall survival, reduce relapse rates, and increase disease-free survival.

A Beacon of Hope for AML Patients

This review provides valuable insights into the current landscape of HSCT for AML. It serves as a guide for healthcare providers and a beacon of hope for individuals with this challenging disease.

Dr. Camel's Conclusion

This comprehensive review of systematic reviews on HSCT for AML offers a valuable roadmap for understanding this complex treatment. It highlights the potential benefits and risks of different HSCT approaches and underscores the need for ongoing research to further optimize this life-saving therapy. It's a reminder that in the desert of AML, there are oases of hope and innovation, offering pathways to recovery for patients.

Date :
  1. Date Completed 2022-10-25
  2. Date Revised 2022-10-25
Further Info :

Pubmed ID

36277468

DOI: Digital Object Identifier

PMC9568333

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.